We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Several Claims on Schering’s Zetia Patent Are Ruled Invalid
Several Claims on Schering’s Zetia Patent Are Ruled Invalid
April 21, 2010
A federal court has ruled certain claims on a patent for Schering-Plough’s cholesterol treatment Zetia are invalid, a move that may help Glenmark
Pharmaceuticals win approval for a generic version of the drug.